Australia's most trusted
source of pharma news
Thursday, 02 July 2026
Thursday, 2 July 2026
Subscribe
Login
News Headlines
News Headlines
News
Next era of blockbusters unveiled
Posted 2 July 2026 AM
Three Eli Lilly drugs are forecast to make up nearly half of the total sales of the world’s top 10 best-selling drugs in 2032, with diabetes drug Mounjaro topping the list at US$45.5 billion.
The list compiled by Evaluate, shows the only drug that comes close to rivalling Lilly’s anti-obesity blockbusters is AbbVie’s Skyrizi, an injectable IL-23 antagonist, which will be the second-biggest selling drug in 2032, at over US$33 billion, given its potential to treat dozens of conditions.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (25)
- Inside Sales Specialist - Melbourne
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Customer Service Representative - Perth
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
Access & Reimbursement (2)
- Head of Access, Sustainability & External Engagement - Melbourne
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
Clinical & Medical, R&D (6)
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Other (12)
- Warehouse Assistant - Eight Mile Plains
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
- Manufacturing Process Engineer - Blacktown
- QC Analyst - Microbiology - Melbourne
- Lab Technician - Victoria
- Senior Recruitment Consultant - Victoria
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.